Drug intelligence / Profile preview

Fengshitong

Development stage: Unknown
Lead developer: Universe Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Fengshitong is a Traditional Chinese Medicine (TCM) derivative developed and manufactured by Universe Pharmaceuticals. It is primarily indicated for the treatment of rheumatism and associated symptoms, including joint pain and muscle aches. The product is typically available in formulations such as medicinal wine and capsules. As a proprietary Chinese medicine, it is composed of a blend of herbal ingredients designed to dispel 'wind-dampness' and alleviate pain according to traditional therapeutic principles. It is marketed as an over-the-counter (OTC) drug in China, targeting the aging population and individuals suffering from chronic inflammatory conditions.

Brand names: Fengshitong
Other names: Fengshitong Medicinal WineFengshitong CapsulesFengshitong YaogiuFengshitong Jiaonang

Beyond the preview

Go deeper on Fengshitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fengshitong.

Explore the full profile